Hyperglycemia / obezita

Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, Alzheimer'S disease, sleep disorders, Parkinson'S disease, AIDS, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

FIELD OF THE INVENTION The present invention relates to transdermal devices and methods for controllable dispensing of a nutraceutical or an active substance such as a chemical substance, a medication, a drug, a stimulant or the like, to a human or other mammal for purposes of promoting longevity,

Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

FIELD OF THE INVENTION The present invention relates to transdermal devices and methods for controllable dispensing of a nutraceutical or an active substance such as a chemical substance, a medication, a drug, a stimulant or the like, to a human or other mammal for purposes of promoting longevity,

Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, AIDs, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

FIELD OF THE INVENTION The present invention relates to transdermal devices and methods for controllable dispensing of a nutraceutical or an active substance such as a chemical substance, a medication, a drug, a stimulant or the like, to a human or other mammal for purposes of promoting longevity,

Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

FIELD OF THE INVENTION The present invention relates to transdermal devices and methods for controllable dispensing of a nutraceutical or an active substance such as a chemical substance, a medication, a drug, a stimulant or the like, to a human or other mammal for purposes of promoting longevity,

Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

FIELD OF THE INVENTION The present invention relates to transdermal devices and methods for controllable dispensing of a nutraceutical or an active substance such as a chemical substance, a medication, a drug, a stimulant or the like, to a human or other mammal for purposes of promoting longevity,

Compositions and methods for the treatment of hyperglycemia and metabolic syndrome

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

FIELD OF THE INVENTION This disclosure generally relates to compounds and compositions for the treatment of diabetes and pre-diabetes. More particularly, this invention relates to treating subjects with a pharmaceutically acceptable dose of compounds, crystals, solvates, enantiomer, stereoisomer,

Compositions and methods for the treatment of hyperglycemia and metabolic syndrome

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

PRIORITY The present application claims the benefit of PCT Application No. PCT/IB2015/056704 filed on Sep. 3, 2015, which further claims benefit of Indian Provisional Patent Application No. 1436/CHE/2015 filed on Mar. 21, 2015, the entire disclosure of which is relied on for all purposes and is

Methods and compositions for the treatment of obesity, insulin related diseases and hypercholesterolemia

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

BACKGROUND OF THE INVENTION (1) Field of the Invention The present invention relates to the treatment of insulin related diseases, obesity, diabetes mellitus, hyperglycemia, lipid disorders, hyperlipidemia, or low HDL, hypercholesterolemia, hyperglyceridemia, dyslipidemia, and atherosclerosis. The

CaMKK.beta. as a target for treating obesity

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

FIELD OF THE INVENTION The present invention concerns compounds, compositions and methods for the treatment of obesity, diabetes, insulin resistance, and hyperglycemia. BACKGROUND OF THE INVENTION U.S. Pat. No. 2,820,037 to Schmidt-Nickels describes compounds useful as intermediates for synthesizing

Therapeutic package for the long term reduction of body fat stores insulin resistance hyperinsulinemia and hyperglycemia in vertebrates

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

1. Field of the Invention This invention relates to an improved process for the reduction in vertebrates, animals or humans, of body fat stores, and reduction of insulin resistance, hyperinsulinemia, which is often associated with insulin resistance, and hyperglycemia, or reduction of plasma

Methods for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates with a prolactin stimulatory compound

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

FIELD OF THE INVENTION This invention relates to an improved process for the reduction in vertebrates, animals or humans, of body fat stores, and reduction of insulin resistance, hyperinsulinemia, which is often associated with insulin resistance, and hyperglycemia, or reduction of plasma glucose.

Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

FIELD OF THE INVENTION This invention relates to an improved process for the reduction in vertebrates, animals or humans, of body fat stores, and reduction of insulin resistance, hyperinsulinemia, which is often associated with insulin resistance, and hyperglycemia, or reduction of plasma glucose.

Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

FIELD OF THE INVENTION This invention relates to an improved process for the reduction in vertebrates, animals or humans, of body fat stores, and reduction of insulin resistance, hyperinsulinemia, which is often associated with insulin resistance, and hyperglycemia, or reduction of plasma glucose.

Method for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

FIELD OF THE INVENTION This invention relates to an improved process for the reduction in vertebrates, animals or humans, of body fat stores, and reduction of insulin resistance, hyperinsulinemia, which is often associated with insulin resistance, and hyperglycemia, or reduction of plasma glucose.

Method for the long term reduction of body fat stores, insulin resistance, hypersinsulinemia and hyperglycemia in vertebrates

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

FIELD OF THE INVENTION This invention relates to an improved process for the reduction in vertebrates, animals or humans, of body fat stores, and reduction of insulin resistance, hyperinsulinemia, which is often associated with insulin resistance, and hyperglycemia, or reduction of plasma glucose.

hyperglycemia/obezita

Compositions and methods for the treatment of hyperglycemia and metabolic syndrome

Compositions and methods for the treatment of hyperglycemia and metabolic syndrome

Methods and compositions for the treatment of obesity, insulin related diseases and hypercholesterolemia

CaMKK.beta. as a target for treating obesity

Therapeutic package for the long term reduction of body fat stores insulin resistance hyperinsulinemia and hyperglycemia in vertebrates

Methods for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates with a prolactin stimulatory compound

Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates

Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates

Method for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates

Method for the long term reduction of body fat stores, insulin resistance, hypersinsulinemia and hyperglycemia in vertebrates

Najkompletnejšia databáza liečivých bylín podporovaná vedou